Funding for this research was provided by:
Gottfried und Julia Bangerter-Rhyner-Stiftung
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (IZ07Z0_160876/1)
Janggen-Pöhn Foundation Switzerland
Received: 28 September 2017
Accepted: 29 January 2018
First Online: 12 February 2018
Ethics approval and consent to participate
: This trial has been approved by the National Health Research and Ethics Committee of the Ministry of Health of Lesotho (ID48–2017, 05.07.2017) and the Ethics committee in Switzerland (Ethikkomission Nordwest- und Zentralschweiz; EKNZ BASEC UBE 2017–00201, 10.04.2017). Prior to randomization, all participants will provide oral and written informed consent: The study nurse/physician will explain the information sheet to participants. Once all open questions have been clarified and upon agreement to participate, the participant will sign the informed consent form. Iliterate participants will provide a thumb-print and a witness (independent to the trial and > 21 years old), chosen by the participant, will co-sign the form. For children and young adults aged < 18 years, a literate caregiver > 21 years old (person that takes care of the child/young adult) will provide oral and written informed consent. The informed consent is provided in English and the local language, Sesotho, and the participant will receive a copy of the consent form in written format to take away.
: not applicable.
: The Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, under the lead of MB receives unrestricted education and research grants from Gilead, MSD, Janssen, and ViiV. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.